Great Point Partners’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,016,375	Closed	-$5.06M	–	31
2024 Q3	$5.06M	Buy	1,016,375 +75,544	+8%	+$376K	1.49%	24
2024 Q2	$5.5M	Buy	+940,831	New	+$5.5M	1.05%	26